These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
55 related articles for article (PubMed ID: 19725339)
1. Sugammadex: A Review of the Considerations for Women of Childbearing Age. Hirsch JG; Chia PA; Jahr JS Am J Ther; 2023 Mar-Apr 01; 30(2):e146-e150. PubMed ID: 36892560 [No Abstract] [Full Text] [Related]
2. Moving perioperative care forward while reversing: Is there hidden benefit to neuromuscular blockade antagonism with sugammadex? Renew JR; Brull SJ J Clin Anesth; 2024 Sep; 96():111357. PubMed ID: 38103989 [No Abstract] [Full Text] [Related]
3. [ESAIC and ASA guidelines for the management of neuromuscular blockade]. Fuchs-Buder T; Lewald H; Kranke P Anaesthesiologie; 2024 Jan; 73(1):51-55. PubMed ID: 38175190 [No Abstract] [Full Text] [Related]
4. Perioperative neuromuscular blockade monitoring - a comparison between tertiary centres and with existing guidelines. Leonard A; McAuliffe N; Baker A; Corbett J; O'Brien B Ir Med J; 2024 Apr; 117(4):947. PubMed ID: 38682695 [No Abstract] [Full Text] [Related]
5. A new approach to anesthesia management in myasthenia gravis: reversal of neuromuscular blockade by sugammadex. de Boer HD; van Egmond J; Driessen JJ; Booij LH Rev Esp Anestesiol Reanim; 2010 Mar; 57(3):181-4. PubMed ID: 20422852 [TBL] [Abstract][Full Text] [Related]
6. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block. Kotake Y; Ochiai R; Suzuki T; Ogawa S; Takagi S; Ozaki M; Nakatsuka I; Takeda J Anesth Analg; 2013 Aug; 117(2):345-51. PubMed ID: 23757472 [TBL] [Abstract][Full Text] [Related]
7. [Assessment of sugammadex use efficiency and safety for neuromuscular block reversion]. Kirienko PA; Babaiants AV; Shmakov IA; Gorobets ES; Él'dzharkiev AA; Gel'fand BR Anesteziol Reanimatol; 2013; (6):46-51. PubMed ID: 24749265 [TBL] [Abstract][Full Text] [Related]